Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OSA Endotyping as Targets for Treatment. How Far Have We Come?

Respirology (Carlton, Vic.)·2026
Same author

The modified Baveno classification for obstructive sleep apnoea: design of a pan-European prospective study.

Sleep medicine·2026
Same author

Sleep apnoea and its consequences: from animal models to precision medicine.

Sleep medicine·2026
Same author

Motor Vehicle Crash Prevention.

The New England journal of medicine·2026
Same author

Behavioral interventions as treatment for insomnia - A scoping review of randomized controlled trials.

Sleep medicine·2025
Same author

European Respiratory Society statement on advanced telemedicine for obstructive sleep apnoea (e-Sleep).

The European respiratory journal·2025
Same journal

Beyond therapeutic maximalism: Prioritization and personalization in preventive therapies.

Progress in cardiovascular diseases·2026
Same journal

Multimodality imaging of vulnerable plaque: Are we there yet? A multifaceted perspective.

Progress in cardiovascular diseases·2026
Same journal

Beyond LDL-C: Triangulating residual risk via lipoprotein(a), remnant cholesterol, and vascular inflammation.

Progress in cardiovascular diseases·2026
Same journal

COVID-19 and coronary atherosclerosis: Unmasking and accelerating?

Progress in cardiovascular diseases·2026
Same journal

Mavacamten and left ventricular dysfunction in hypertrophic cardiomyopathy with left bundle branch block.

Progress in cardiovascular diseases·2026
Same journal

Lessons from ATTR-CM clinical trials: Progress, persistent disparities, and emerging treatment dilemmas.

Progress in cardiovascular diseases·2026
See all related articles

Related Experiment Video

Updated: Jun 25, 2026

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
04:53

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on: October 18, 2024

Obstructive sleep apnea and inflammation.

Walter T McNicholas1

  • 1Sleep Research Laboratory, St. Vincent's University Hospital, Dublin, Ireland. walter.mcnicholas@ucd.ie

Progress in Cardiovascular Diseases
|March 3, 2009
PubMed
Summary
This summary is machine-generated.

Inflammation contributes to cardiovascular issues in obstructive sleep apnea syndrome (OSAS). Elevated inflammatory markers in OSAS patients suggest a link between sleep apnea, inflammation, and heart disease risk.

Related Experiment Videos

Last Updated: Jun 25, 2026

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
04:53

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on: October 18, 2024

Area of Science:

  • Cardiovascular Science
  • Sleep Medicine
  • Immunology

Background:

  • Cardiovascular complications are a significant concern in obstructive sleep apnea syndrome (OSAS).
  • Inflammation is a key factor in atherosclerosis and is linked to cardiovascular risk.
  • Several inflammatory markers are associated with increased cardiovascular risk.

Purpose of the Study:

  • To explore the role of inflammatory processes in the cardiovascular pathophysiology of OSAS.
  • To investigate the association between elevated inflammatory markers and cardiovascular risk in OSAS patients.

Main Methods:

  • Review of existing literature on inflammation, OSAS, and cardiovascular disease.
  • Analysis of studies reporting inflammatory marker levels in OSAS patients.
  • Examination of animal and cell culture studies on intermittent hypoxia and inflammatory pathways.

Main Results:

  • Circulating levels of inflammatory markers like intercellular adhesion molecule-1, selectins, tumor necrosis factor alpha, interleukin 6, interleukin 8, and C-reactive protein are linked to cardiovascular risk.
  • Many of these inflammatory markers are elevated in patients with OSAS.
  • Intermittent hypoxia, characteristic of OSAS, preferentially activates inflammatory pathways.

Conclusions:

  • Inflammatory processes are implicated in the cardiovascular complications of OSAS.
  • Further research is needed to clarify the precise role of inflammation in OSAS-related cardiovascular disease, its connection to oxidative stress, metabolic dysfunction, and obesity.